Sage Therapeutics, Inc (SAGE) Book Value per Share
The book value per share of Sage Therapeutics, Inc. (SAGE) demonstrates genuine capital resilience, where the 5.93 metric determines this level. Management possesses deep expertise in neuroscience and ensures transparency across all research stages. The US manufacturer focuses on the therapy of depressive states, relying on support from Biogen. Current success is based on the implementation of Zurzuvae, despite the reduction of certain Alzheimer's programs.
Summary analytical data breakdowns for sagerx.com (SAGE)
- stock price and consensus target price:
- market capitalization details:
- business book valuation details:
- debt and liquidity details:
Total Debt to Equity Ratio Sage Therapeutics, Inc.|SAGE - Long-Term Debt to Capital|Short-Term Debt to Equity Sage Therapeutics|SAGE - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Sage Therapeutics, Inc.|SAGE - Long-Term Debt|Company Short-Term Debt Sage Therapeutics|Quick Ratio sagerx.com
- earnings and multiples data:
General company analysis:SAGE - Sage Therapeutics, Inc
An investment audit of Sage Therapeutics, Inc. (SAGE) requires an analysis of the book value per share, calculated as the difference between total assets and liabilities divided by the number of shares outstanding. Amid biotech portfolio optimization and a reliance on new product sales, the target book value per share serves as an indicator of actual capital preservation, excluding market volatility.
Main competitors
Biogen Corp - Book Value per Share|Book Value of One Share Neurocrine Corp (NBIX)|RGC: Book Value per Share|Net Asset Value per Share axsome.com (AXSM)|Net Assets per Single Share ACADIA Pharmaceuticals Inc.|Equity per Share XENE (Xenon Pharmaceuticals Inc.)|Book Value per Share VKTX|SUPN - Net Asset Value per Share|Catalyst Pharmaceuticals - Accounting Value per Share|Book Value per Share denalitherapeutics.com DNLI|HRMY - Net Assets per Single Share|Accounting Value of a Share BHVN (Biohaven Ltd)|Amylyx (AMLX) - Net Assets per Single Share|Net Asset Value per Share Trevi Corp (TRVI)|Net Assets per Single Share Praxis Precision Medicines|anavex.com (AVXL) - Net Assets per Share|Book Value per Share CBLL|Book Value per Share Prothena Corporation (PRTA)|Book Value per Share ALEC (Alector)|Book Value of One Share Annexon Biosciences Inc.|Omeros Corp. - Book Value per Share|Net Asset Value per Share neurogene.com|ACIU (AC Immune SA) - Accounting Value per Share|Voyager Therapeutics Inc - Accounting Value of a Share|Accounting Value per Share NMRA|SCLX (Scilex Holding Company, Inc.) - Book Price of a Share|Book Value per Share TVGN|ACOG (alphacognition.com) - Accounting Value of a Share|Book Value per Share CGTX (Cognition Therapeutics)|Inhibikase Therapeutics Inc (IKT) - Net Asset Value per Share|SAVA - Net Assets per Single Share|Accounting Value of a Share ASRT (Assertio Holdings, Inc.)|COYA: Book Value per Share|Vistagen (VTGN) - Book Value per Share|Net Assets per Single Share Ovid Therapeutics Inc|Acumen Pharmaceuticals Inc. - Share Book Value|Book Value per Share CRVO|ATHE - Net Asset Value per Share|Clene - Accounting Value per Share|Book Value per Share PepGen Inc PEPG|JUNS: Accounting Value per Share|Relmada Therapeutics Inc - Book Price of a Share|ANVS: Book Value per Share|GRCE - Net Assets per Share|AIFF (Firefly Neuroscience, Inc) - Book Value per Share|Accounting Value per Share ANEW Medical, Inc. (KLTO)|Net Assets per Single Share NeuroSense Therapeutics (NRSN)|Net Assets per Share Reviva Pharmaceuticals Holdings Inc.|MetaVia - Accounting Value per Share|Accounting Value of a Share NRXS|Helius Medical Technologies Inc. - Book Value per Share|Net Assets per Share Passage Bio, Inc. PASG|bionomics.com.au (NEUP) - Net Assets per Single Share|Equity per Share NERV|ATHA (Athira) - Book Value per Share|Accounting Value per Share Addex (ADXN)|Accounting Value per Share ALZN (Alzamend Neuro, Inc.)|Net Assets per Share cyclerion.com|Net Assets per Single Share Protagenic Therapeutics, Inc. PTIX|Net Assets per Share Pasithea Therapeutics Corp (KTTA)|Cortigent Medical - Book Value per Share|ATXI - Book Value per Share|BCLI: Book Value per Share|Book Value of One Share caratherapeutics.com CARA|CHRO (Chromocell Therapeutics Corp.) - Book Value per Share|Net Asset Value per Share Eliem ELYM|Net Assets per Single Share Intra-Cellular Therapies (ITCI)|Longboard - Equity per Share|Book Value per Share MRNS (Marinus Pharmaceuticals)|nkgenbiotech.com (NKGN) - Net Asset Value per Share|NRBO: Accounting Value per Share|SNPX - Book Value per Share|Trevena, Inc (TRVN) - Net Assets per Single Share|Vigil Neuroscience, Inc. - Accounting Value of a Share|Net Assets per Single Share Anew Medical|Net Asset Value per Share cerevel.com CERE